...
首页> 外文期刊>Artificial cells, nanomedicine, and biotechnology. >Nano-loaded human umbilical cord mesenchymal stem cells as targeted carriers of doxorubicin for breast cancer therapy
【24h】

Nano-loaded human umbilical cord mesenchymal stem cells as targeted carriers of doxorubicin for breast cancer therapy

机译:纳米负载人脐带间充质干细胞作为阿霉素的靶向载体用于乳腺癌治疗

获取原文
           

摘要

The main challenge of anticancer drugs is poor tumor targeting. Now cellular carriers are widely investigated to deliver anticancer agents. As an ideal cellular candidate, human umbilical cord derived mesenchymal stem cells (hUC-MSCs) possess inherent tropism potential to tumor. Here, we constructed hUC-MSCs carrying transferrin-inspired-nanoparticles that contain doxorubicin(hUC-MSCs-Tf-inspired-NPs) to achieve enhanced anti-tumor efficacy and made an evaluation. Results represented that hUC-MSCs-Tf-inspired-NPs not only exhibit the controlled-release property of Tf-inspired-NPs, but also integrate tumor tropism and penetrative abilities of MSCs. The tumor volume of nude mice bearing breast cancer MCF-7 treated with hUC-MSCs-Tf-inspired-NPs, was remarkably reduced compared to those treated with free drug or Tf-inspired-NPs. Thus, Tf-inspired-NPs loaded hUC-MSCs have a potential to deliver anticancer drugs.
机译:抗癌药物的主要挑战是肿瘤靶向性差。现在,细胞载体被广泛研究以递送抗癌剂。作为理想的细胞候选物,人脐带来源的间充质干细胞(hUC-MSC)具有与肿瘤固有的向性潜能。在这里,我们构建了带有载有阿霉素的转铁蛋白启发的纳米颗粒的hUC-MSC(hUC-MSCs-Tf启发的NPs),以实现增强的抗肿瘤功效并进行了评估。结果表明,hUC-MSCs-Tf激发的NPs不仅表现出Tf激发的NPs的控释特性,而且还整合了肿瘤的向性性和MSCs的穿透能力。与用游离药物或Tf激发的NPs治疗的小鼠相比,用hUC-MSCs-Tf激发的NPs治疗的携带乳腺癌MCF-7的裸鼠的肿瘤体积显着降低。因此,受Tf启发的NPs加载的hUC-MSC具有传递抗癌药物的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号